Key statistics dashboard for BGM Group Ltd. (BGM). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China.
Stock Data
| Price | $9.35 |
| Market Cap | $119M |
| Enterprise Value | $108.3M |
| Beta | 1.93 |
| Exchange | NASDAQ |
| Country | CN |
Valuation Multiples
| P/E Ratio | -1.93 |
| Price / Book | 0.15 |
| P/S | 2.48 |
| EV/EBITDA | -11.71 |
| EV/Sales | 2.26 |
| EV/FCF | 74.15 |
| P/FCF | 81.23 |
| Earnings Yield | -36.62% |
| FCF Yield | 1.23% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 12.81% |
| EBIT Margin | -23.42% |
| EBITDA Margin | -19.31% |
| Operating Margin | -23.42% |
| Net Margin | -44.22% |
| Return on Equity | -5.37% |
| Return on Assets | -4.85% |
| Return on Invested Capital | -2.80% |
| Return on Capital Employed | -2.81% |
Financial Health
| Current Ratio | 1.25 |
| Quick Ratio | 0.65 |
| Cash Ratio | 0.31 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.27% |
| Net Debt / EBITDA | 1.12 |
| Interest Coverage | -991.63 |
Per-Share Data
| Revenue per share | 7.74 |
| Book Value per share | 64.65 |
| Cash per share | 1.87 |
| FCF per share | 0.24 |
| Tangible Book Value per share | 5.71 |
| Dividend per share | 0.00 |
Related companies: ANIP · AVDL · CLOV · EWTX · GPCR · MESO · PAHC
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of BGM: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks